Clinical Updates in Reproductive Health

Postabortion IUD use: Safety and timing

Last reviewed: February 15, 2021

Recommendation:

  • When a woman chooses an intrauterine contraceptive device (IUD), it should be placed immediately following a successful, uncomplicated vacuum aspiration or dilatation and evacuation (D&E) abortion.

  • When a woman chooses an IUD following medical abortion, it should be placed when it is reasonably certain she is no longer pregnant.

Strength of recommendation: Strong

Quality of evidence: High

IUD placement after abortion before 13 weeks gestation

The World Health Organization’s (WHO) 2015 Medical Eligibility Criteria for Contraceptive Use classifies IUDs as category one, or safe for immediate use, following first-trimester abortion; recommendations do not differ based on type of abortion.

In comparison to short-acting methods, long-acting reversible methods of contraception such as implants and IUDs have higher continuation rates and lower pregnancy and abortion rates (Blumenthal, Wilson, Remsburg, Cullins, & Huggins, 1994; Cameron et al., 2012; Korjamo, Mentula & Heikinheimo, 2017b; Langston, Joslin-Rohr, & Westhoff, 2014; Peipert, Madden, Allsworth, & Secura, 2012; Pohjoranta, Mentula, Gissler, Suhonen, & Heikinheimo, 2015; Roberts, Silva, & Xu, 2010). A 2014 Cochrane review of 12 trials including 7,119 women concluded that IUD insertion following vacuum aspiration and D&E is safe and practical (Okusanya, Oduwole, & Effa, 2014). The review found no differences in serious adverse events, such as infection or perforation, between immediate and delayed insertion. A 2011 trial randomized 575 women to immediate or delayed IUD insertion after uterine aspiration before 12 weeks (Bednarek et al., 2011). Although rates of IUD expulsion were slightly higher following immediate postabortion insertion (5% compared to 2.7%), women assigned to the delayed

insertion group were significantly less likely to receive an IUD (75% compared to 100% in the immediate group) and more likely to have a subsequent pregnancy (five women compared to none). A historical cohort study compared immediate postprocedure IUD insertion performed by midlevel providers to physicians, and found no difference in adverse outcomes between the two groups (Patil et al., 2016).

Following a medical abortion before 13 weeks gestation, IUDs may be placed as soon as it is reasonably certain that a woman is no longer pregnant (WHO, 2014; WHO, 2018). IUDs placed within 5-10 days of a successful medical abortion have low rates of expulsion, high continuation rates (Betstadt, Turok, Kapp, Feng, & Borgatta, 2011; SƤƤv, Stephansson, & Gemzell-Danielsson, 2012) and lower pregnancy rates than delayed insertion (Pohjoranta, Suhonen, Mentula, & Heikinheimo, 2017; Saav et al., 2012; Shimoni, Davis, Ramos, Rosario, & Westhoff, 2011). A systematic review of three randomized trials found no differences between early and delayed insertion after abortion at gestations less than nine weeks, and higher rates of expulsion, continuation and uptake after immediate compared to delayed insertion at 9–12 weeks of gestation (Schmidt-Hansen et al., 2020). Uptake of IUDs is higher after surgical abortion as compared to medical abortion, despite similar contraceptive choices and desires (Fang, Sheeder, & Teal, 2018; Rocca et al., 2018).

IUD placement after abortion at or after 13 weeks gestation

The WHO Medical Eligibility Criteria for Contraceptive Use (2015) classifies IUD use following uncomplicated second-trimester abortion as category two, meaning the advantages of using the method outweigh risks, due to an increased risk of IUD expulsion. The Cochrane review of immediate postabortion insertion of IUDs following an abortion procedure referenced above concluded that although expulsion rates may be higher with immediate placement, continuation is higher with no increase in complications (Okusanya et al., 2014). In two randomized controlled trials of immediate versus delayed IUD placement after D&E, rates of IUD use were significantly higher with immediate insertion, without an increase in infection or complication rates (Cremer et al., 2011; Hohmann et al., 2012). Expulsion rates for women who had immediate insertion in both studies were low (3.1% and 6.8%) and were not different from delayed insertion. Notably, in both studies, about half of women randomized to delayed insertion did not return to have the IUD inserted. Requiring a follow-up visit for IUD insertion is a significant barrier to obtaining the IUD (Stanek, Bednarek, Nichols, Jensen, & Edelman, 2009).

The only available study of IUD placement immediately following medical abortion at or after 13 weeks gestation found that insertion is feasible and safe, however the study was underpowered to assess rate of expulsions (Korjamo, Mentula, & Heikinheimo, 2017a; Korjamo et al., 2017b).The WHO Medical Eligibility Criteria for Contraceptive Use (2015) recommendations for IUD use after second-trimester abortion do not differ based on the type of abortion performed, whether medical or surgical. Although not directly translatable, the evidence from post-partum IUD insertion is reassuring (Lopez, Bernholc, Hubacher, Stuart, & Van Vliet, 2015). An IUD may be placed following fetal and placental expulsion.

Young women

The IUD for women under the age of 20 is classified by WHO as category two, in which the benefits generally outweigh the risks (WHO, 2015). A large, US-based, prospective cohort study which examined pregnancy, birth and abortion rates in women provided all birth control methods at no cost included 1,056 women under the age of 20 and found that 62% of young women chose a long acting reversible contraceptive method—either the IUD (22%) or implant (40%)—compared to 71% of older women (Mestad et al., 2011). Continuation rates at 12 and 24 months were the same among older and younger women (Birgisson, Zhao, Secura, Madden & Peipert, 2015). Pregnancy, birth and induced abortion rates among the young women in the study were reduced by 75% compared to national averages (Secura et al., 2014).

A large 2017 systematic review and meta-analysis exploring risk factors for repeat pregnancies among teens, which included 26 studies reporting on more than 160,000 adolescent women, found that use of long acting reversible contraceptives exerted a significant protective effect, along with improved educational attainment and school continuation (Maravilla, Betts, Couto e Cruz, & Alati, 2017).

A 2017 systematic review examining risk of adverse outcomes in young women using the IUD found no differences in rates of perforation, contraceptive failure, pelvic inflammatory disease, or heavy bleeding in women younger than 25 compared to older women; rates of IUD expulsion were slightly higher in young women (Jatlaoui, Riley, & Curtis, 2017). IUDs do not increase young women’s risk of infertility (Grimes, 2000), and women’s fertility returns to baseline rates rapidly following IUD removal (Hov, Skjeldestad, & Hilstad, 2007).

References

Bednarek, P. H., Creinin, M. D., Reeves, M. F., Cwiak, C., Espey, E., & Jensen, J. T. (2011). Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine, 364(23), 2208-2217.

Betstadt, S. J., Turok, D. K., Kapp, N., Feng, K. T., & Borgatta, L. (2011). Intrauterine device insertion after medical abortion. Contraception, 83(6), 517-521.

Birgisson, N. E., Zhao, Q., Secura, G. M., Madden, T., & Peipert, J. (2015). Preventing unintended pregnancy: The Contraceptive CHOICE Project in review. Journal of Women’s Health Larchmont, 24(5), 349-353.

Blumenthal, P. D., Wilson, L. E., Remsburg, R. E., Cullins, V. E., & Huggins, G. R. (1994). Contraceptive outcomes among post-partum and post-abortal adolescents. Contraception, 50(5), 451-460.

Cameron, S., Glasier, A., Chen, Z., Johnstone, A., Dunlop, C., & Heller, R. (2012). Effect of contraception provided at termination of pregnancy and incidence of subsequent termination of pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 119(9), 1074-1080

Cremer, M., Bullard, K. A., Mosley, R. M., Weiselberg, C., Molaei, M., Lerner, V., & Alonzo, T. A. (2011). Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation. Contraception, 83(6), 522-527.

Fang, N., Sheeder, J., & Teal, S. (2018). Factors associated with initiating long-acting reversible contraception immediately after first-trimester abortion. Contraception, 98, 292-295.

Grimes, D. (2000). Intrauterine device and upper genital tract infection. The Lancet, 356, 1013-1019.

Hohmann, H. L., Reeves, M. F., Chen, B. A., Perriera, L. K., Hayes, J. L., & Creinin, M. D. (2012). Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: A randomized controlled trial. Contraception, 85(3), 240-245.

Hov, G. G., Skjeldestad, F. E., & Hilstad, T. (2007). Use of IUD and subsequent fertility-follow-up after participation in a randomized clinical trial. Contraception, 75, 88-92.

Jatlaoui, T. C., Riley, H. E. M., & Curtis, K. (2017). The safety of intrauterine devices among young women: A systematic review. Contraception, 95, 17-39.

Korjamo, R., Mentula, M., & Heikinheimo, O. (2017a). Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of later first- and second-trimester pregnancy: A randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology, https://doi.org/10.1111/147-0528.14813.

Korjamo, R., Mentula, M., & Heikinheimo, O. (2017b). Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy – 1 year continuation rates: A randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology, https://doi.org/10.1111/1471-0528.14802.

Langston, A. M., Joslin-Roher, S. L., & Westhoff, C. L. (2014). Immediate postabortion access to IUDs, implants and DMPA reduces repeat pregnancy within one year in a New York City practice. Contraception, 89(2), 103-108.

Lopez, L. M., Bernholc, A., Hubacher, D., Stuart, G., & Van Vliet, H. A. (2015). Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database of Systematic Reviews, 26(6): CD003036. DOI: 10.1002/14651858.CD003036.pub3.

Maravilla, J. C., Betts, K. S., Cuoto e Cruz, C., & Alati, R. (2017). Factors influencing repeated teenage pregnancy: A review and meta-analysis. Australian Journal of Obstetrics & Gynecology, 527-545.

Mestad, R., Secura, G., Allsworth, J. E., Madden, T., Zhou, Q., & Peipert, J. (2011). Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception, 84(5), 493-498.

Okusanya, B. O., Oduwole, O., & Effa, E. E. (2014). Immediate postabortal insertion of intrauterine devices. Cochrane Database of Systematic Reviews, 7, DOI: 10.1002/14651858.CD001777.pub4.

Patil, E., Darney, B., Orme-Evans, K., Beckley, E. H., Bergander, L., Nichols, M., & Bednarek, P. H. (2016). Aspiration abortion with immediate intrauterine device insertion: Comparing outcomes of advanced practice clinicians and physicians. Journal of Midwifery and Women’s Health, 61(3), 325-330. DOI:10.1111/jmwh.12412

Peipert, J. F., Madden, T., Allsworth, J. E., & Secura, G. M. (2012). Preventing unintended pregnancies by providing no-cost contraception. Obstetrics & Gynecology, 120(6), 1291-1297.

Pohjoranta, E., Mentula, M., Gissler, M., Suhonen, S., & Heikinheimo, O. (2015). Provision of intrauterine contraception in association with first trimester induced abortion reduces the need of repeat abortion: First-year results of a randomized controlled trial. Human Reproduction, 30(11), 2539-46.

Pohjoranta, E., Suhonen, S., Mentula, M., & Heikinheimo O. (2017). Intrauterine contraception after medical abortion: Factors affecting success of early insertion. Contraception, 95(3), 257-262.

Roberts, H., Silva, M., & Xu, S. (2010). Post abortion contraception and its effect on repeat abortions in Auckland, New Zealand. Contraception, 82(3), 260-265.

Rocca, C. H., Goodman, S., Grossman, D., Cadwallader, K., Thompson, K. M. J., Talmont, E., . . . Harper, C. C. (2018). Contraception after medication abortion in the United States: results from a cluster randomized trial. American Journal of Obstetrics & Gynecology, 218(1), 107.e101-107.e108

SƤƤv, I., Stephansson, O., & Gemzell-Danielsson, K. (2012). Early versus delayed Insertion of intrauterine contraception after medical abortion—A randomized controlled trial. PLoS One, 7(11), e48948.

Schmidt- Hansen, M., Hawkins, J.E., Lord, J., Williams, K., Lohr, P.A., Hasler, E., & Cameron, S. (2020). Long-acting reversible contraception immediately after medical abortion: systematic review with meta-analyses. Human Reproduction Update, 26(2), 141-160.

Secura, G. M., Madden, T., McNicholas, C., Mullersman, J., Buckel, C. M., Zhao, Q., & Peipert, J. (2014). Provision of no-cost, long-acting contraception and teenage pregnancy. New England Journal of Medicine, 371(14), 1316-1323.

Shimoni, N., Davis, A., Ramos, M. E., Rosario, L., & Westhoff, C. (2011). Timing of copper intrauterine device insertion after medical abortion: A randomized controlled trial. Obstetrics & Gynecology, 118(3), 623-628.

Stanek, A. M., Bednarek, P. H., Nichols, M. D., Jensen, J. T., & Edelman, A. B. (2009). Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion. Contraception, 79(3), 216-220.

World Health Organization. (2014). Clinical practice handbook for safe abortion. Geneva: World Health Organization Press.

World Health Organization. (2015). Medical eligibility criteria for contraceptive use (5th ed.). Geneva: World Health Organization Press.

World Health Organization. (2018). Medical management of abortion. Geneva: World Health Organization Press.

About Us

We work with partners around the world to advance reproductive justice by expanding access to abortion and contraception.

Ipas Sustainable Abortion Care

Our Work

The global movement for legal, accessible abortion is growing. Our staff and partners in countries as diverse as Bolivia, Malawi and India are working to ensure all people can access high-quality abortion care.

Where We Work

The global movement for legal, accessible abortion is growing. Our staff and partners in countries as diverse as Bolivia, Malawi and India are working to ensure all people can access high-quality abortion care.

Resources

Our materials are designed to help reproductive health advocates and professionals expand access to high-quality abortion care.

For health professionals

For advocates and decisionmakers

Training
resources

For humanitarian settings

Abortion VCAT resources

For researchers and program implementors